Evidence method
Level · gp.fundamentals.capex_revenue_ratio
14450.00% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CLDX · Jun 30, 2026
Celldex Therapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001104659-26-091984General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-260954.55% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-96.99% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-366468.18% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
307009.09% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
38218.18% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History9 statesHistory building
Period transition
What moved in the state?
- Previous
- 10926.67%
- Current
- 14450.00%
- Delta
- 3523.33%
- Previous
- -437253.33%
- Current
- -260954.55%
- Delta
- 176298.79%
- Previous
- -97.84%
- Current
- -96.99%
- Delta
- 0.86%
- Previous
- -562900.00%
- Current
- -366468.18%
- Delta
- 196431.82%
- Previous
- 486673.33%
- Current
- 307009.09%
- Delta
- -179664.24%
- Previous
- 56820.00%
- Current
- 38218.18%
- Delta
- -18601.82%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · In Vitro & In Vivo Diagnostic Substances peers →Derived From · CLDX Company Quality Vector →Has State · Celldex Therapeutics, Inc. →Transitioned To · CLDX Fundamental State →Transitioned To · CLDX CAPEX_INTENSITY_INCREASED →Transitioned To · CLDX CASH_GENERATION_INCREASED →Transitioned To · CLDX GROWTH_INCREASED →Transitioned To · CLDX PROFITABILITY_INCREASED →Transitioned To · CLDX R_AND_D_INTENSITY_DECREASED →Transitioned To · CLDX SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.